Science
Lululemon Sinks on Lower Guidance: Here's Where the Stock Could Be Headed Next
Let's delve into the charts and see what's in store for the shares.
What's Next for AbbVie Now That It Reached Our Price Target?
Let's review the charts and indicators.
Replimune Breaks Out: Could Rise 30% From Here
Let's check out the charts and indicators of this biotech name.
Struggling 3M Needs to Form a Base, but Lowered Guidance Won't Help
The diversified technology giant has been bearish for months and is likely to remain so after reducing its full-year revenue and profit forecasts.
Bearish Bets: 3 Stocks You Should Think About Shorting This Week
These recently downgraded names are displaying both quantitative and technical deterioration.
My Strategy to Buy Beam Therapeutics
Let's look at the charts and indicators.
Illumina Gets a Fundamental Bump
Here's where aggressive traders could look to probe the long side of ILMN.
For DOCS, the Writing Is on the Wall
Doximity has not finished its decline, according to the charts.
Here's Where DexCom Could Rally
Let's look at the charts and indicators.
United Therapeutics May Need to Take a Breather From the Rally
Let's look at the charts of the biotech.